Business Description
Arch Biopartners Inc
NAICS : 325412
SIC : 3741
ISIN : CA03938C1041
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -3.6 | |||||
Debt-to-Equity | -0.77 | |||||
Debt-to-EBITDA | -2.84 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 13.4 | |||||
3-Year EPS without NRI Growth Rate | 11.7 | |||||
3-Year FCF Growth Rate | 50 | |||||
3-Year Book Growth Rate | -11.2 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 65.14 | |||||
9-Day RSI | 71.4 | |||||
14-Day RSI | 70.92 | |||||
6-1 Month Momentum % | -37.08 | |||||
12-1 Month Momentum % | 38.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.23 | |||||
Quick Ratio | 0.23 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1 | |||||
Shareholder Yield % | -0.32 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -122.86 | |||||
ROIC % | -41.01 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -71.83 | |||||
EV-to-EBITDA | -71.83 | |||||
EV-to-Forward-Revenue | 50.96 | |||||
EV-to-FCF | -93.08 | |||||
Earnings Yield (Greenblatt) % | -1.39 | |||||
FCF Yield % | -1.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Arch Biopartners Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.034 | ||
Beta | 1.93 | ||
Volatility % | 69.54 | ||
14-Day RSI | 70.92 | ||
14-Day ATR (C$) | 0.069485 | ||
20-Day SMA (C$) | 1.7265 | ||
12-1 Month Momentum % | 38.53 | ||
52-Week Range (C$) | 0.97 - 2.56 | ||
Shares Outstanding (Mil) | 64.65 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Arch Biopartners Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Arch Biopartners Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Arch Biopartners Inc Frequently Asked Questions
What is Arch Biopartners Inc(TSXV:ARCH)'s stock price today?
When is next earnings date of Arch Biopartners Inc(TSXV:ARCH)?
Does Arch Biopartners Inc(TSXV:ARCH) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |